Trastuzumab Lyophilized Powder For Concentrate For Solution For Infusion

Trastuzumab Lyophilized Powder For Concentrate For Solution For Infusion Specification

Salt Composition
Trastuzumab

Indication
HER2-positive breast cancer, HER2-positive metastatic gastric cancer

Dosage Form
Lyophilized Powder for Concentrate for Solution for Infusion

Enzyme Types
Monoclonal Antibody (mAb), not an enzyme

Feature
High purity, sterile, preservative-free, ready for reconstitution

Ingredients
Trastuzumab lyophilized powder, excipients

Application
Intravenous infusion after reconstitution and dilution

Ph Level
As per company norms

Physical Color/Texture
White to pale yellow lyophilized cake

Fermentation Smell
Normal Smell

Enzymatic Activity
Not applicable; monoclonal antibody

Storage Instructions
Dry place

Shelf Life
upto 24 Months

Marketed By
Various manufacturers (branding may vary)

Route of Administration
Intravenous

Strength/Concentration
Typically 150 mg or 440 mg per vial

Reconstitution Solvent
Sterile water for injection

Container Material
Glass vial with rubber stopper and aluminum seal

Time to Reconstitute
Reconstitute immediately prior to dilution; use within 24 hours if stored at 2-8C after reconstitution

Compatibility
Incompatible with dextrose-containing solutions

Preparation Precaution
Handle under aseptic conditions; inspect visually for particulate matter and discoloration prior to administration

Packaging Type
Single-use vial

Prescription/OTC Status
Prescription only

Dilution Fluid
0.9% Sodium Chloride Injection (normal saline), do not use dextrose solution

Product Type
Prescription medication, anti-cancer biological

Trastuzumab Lyophilized Powder For Concentrate For Solution For Infusion Trade Information

Minimum Order Quantity
1 Unit

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Units Per Month

Delivery Time
7-10 Seconds

Main Domestic Market
All India

About Trastuzumab Lyophilized Powder For Concentrate For Solution For Infusion

Trastuzumab Lyophilized Powder for Concentrate for Solution for Infusion is an acclaimed anti-cancer biological, formulated specifically for HER2-positive breast and metastatic gastric cancers. Available in customizable strengths of 150 mg or 440 mg, it is offered at a special rate for wholesalers and exporters in India. The product ensures unrivaled purity, is preservative-free, and packed in a perfectly polished single-use glass vial with an aluminum seal. Its ready-to-reconstitute format delivers optimal results under aseptic conditions, ensuring safe and effective intravenous administration. Only normal saline should be used-never dextrose solutions.

Unrivaled Features and Clinical Applications

Trastuzumab Lyophilized Powder is distinguished by its high purity and sterile preparation, making it the perfect choice for healthcare professionals treating HER2-positive cancers. This prescription-only monoclonal antibody is provided as a white to pale yellow lyophilized cake, ready for reconstitution. Used by oncologists and hospital pharmacies, the polished glass vial ensures optimal integrity for each dose. Its compatibility, preservative-free formulation, and single-use design support safe handling and accurate dosing.

Stock Ready for Export: Shipping, Market, and Packaging

Trastuzumab Lyophilized Powder is available for international export with stock ready for prompt shipping. We offer secure packaging-single-use glass vials with rubber stoppers and aluminum seals-to maintain product integrity during transit. Main export markets include Asia, the Middle East, and Europe. FOB port options are available upon request. Each order is shipped with detailed usage and storage instructions, ensuring seamless delivery and quality assurance from manufacturer to healthcare setting.

FAQ's of Trastuzumab Lyophilized Powder For Concentrate For Solution For Infusion:

Q: How should Trastuzumab Lyophilized Powder be reconstituted and stored?

A: Reconstitute the powder immediately prior to dilution using sterile water for injection. Once reconstituted, it must be further diluted with 0.9% sodium chloride injection and used within 24 hours if kept at 2-8C.

Q: What is the correct way to administer Trastuzumab Lyophilized Powder?

A: The medication is intended for intravenous infusion after proper reconstitution and dilution. It must never be administered with dextrose-containing solutions due to incompatibility.

Q: Where can Trastuzumab Lyophilized Powder be sourced from?

A: Trastuzumab Lyophilized Powder is marketed and exported by various manufacturers across India. Branding may vary but all adhere to pharmaceutical standards outlined by regulatory authorities.

Q: What are the preparation precautions for this product?

A: Always handle under aseptic conditions. Inspect the solution visually for particulate matter or discoloration before administration and follow prescribed storage and disposal protocols.

Q: Who is the primary user of Trastuzumab Lyophilized Powder?

A: This product is prescribed by oncologists and administered by healthcare professionals, primarily used in hospital and specialized cancer treatment settings for patients with HER2-positive breast and metastatic gastric cancers.